Menopur

Menotrophin, the active ingredient in Menopur, is a gonadotropin (FSH/LH) presented as an injectable powder for reconstitution for intramuscular or subcutaneous use. It is employed to stimulate ovarian follicular development and ovulation in women with specific reproductive disorders. GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Menopur is a gonadotropin used in reproductive medicine to support follicular growth and ovulation. - Infertility due to anovulation: promotes follicular development to achieve ovulation in women who do not ovulate spontaneously. - Controlled ovarian stimulation for assisted reproductive technologies (e.g., IVF): enhances the number of mature oocytes retrieved for fertilisation. - Hypogonadotropic hypogonadism: replaces deficient endogenous gonadotropins to restore normal ovarian function.

Menopur may cause a range of adverse reactions, most of which are related to its hormonal activity and injection site.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the administration site. - Abdominal bloating or discomfort: transient gastrointestinal symptoms. - Mild ovarian hyperstimulation: enlarged ovaries with mild discomfort.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): severe ovarian enlargement, fluid shift, and potential thromboembolic events. - Multiple pregnancy: increased risk of twins or higher-order gestations. - Allergic reaction: rash, urticaria, or anaphylaxis in rare cases.

Before initiating Menopur therapy, clinicians should assess patient suitability and monitor response closely. - Monitor ovarian response: perform ultrasound and estradiol measurements to adjust dosing. - Avoid use in pregnancy: the drug is intended for pre‑conception stimulation only. - Assess for hypersensitivity: discontinue if signs of allergic reaction appear. - Use caution in patients with ovarian cysts or a history of OHSS. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur may interact with other hormonal agents and medications that affect ovarian function.

Major Interactions (Avoid): - GnRH antagonists: can blunt the stimulatory effect of Menotrophin. - Oral contraceptives: suppress endogenous gonadotropins, reducing efficacy. - Hormonal therapies that suppress FSH/LH: may counteract Menopur action.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: altered metabolism may affect response. - Corticosteroids: may influence ovarian response and fluid balance. - Anticoagulants: monitor for bleeding if ovarian enlargement occurs.